Publications
95
Citations
853
Est. group size
~38
Recurring co-author estimate
Active years
7
Publishing since 2020
Typically publishes in teams of ~5 · 33% small-team papers (≤3 authors) · across 4 venues
- Therapy-resistant subclones as drivers of progression in aggressive variant prostate cancer.
Journal of Clinical Oncology · 2026
- Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Abstract A034: Development of a novel class of genomic biomarkers through mathematical modeling of cancer genome contiguity
Cancer Research · 2024
- Development of Novel Methods to Study Chromosomal Instability and Genetic Heterogeneity for Biomarker Identification
Deep Blue (University of Michigan) · 2024
- MHCnvex: Likelihood-based model for calling the copy number variations and loss of heterozygosity in MHC class I and II locus
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- HLAProphet: Personalized allele-level quantification of the HLA proteins
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Cancer Research×11
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Cancer Cell×2
- Cell×2
- Cell Reports Medicine×2
- Xuhong Cao
Medicine · University of Michigan
- Aqila Ahmed
Medicine · University of Michigan
- Scott A. Tomlins
Medicine · University of Michigan
- Lakshmi P. Kunju
Medicine · University of Michigan
- Udit Singhal
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile